Cover and Introduction |
Preface |
Executive Summary |
I. |
|
The Promise of Vaccines |
II. |
|
The Mission of the National Vaccine Program and Purpose of the
National Vaccine Plan |
III. |
|
Disease Prevention Through Vaccine Development and Immunization |
IV. |
|
The Goals, Objectives, and Strategies of the National Vaccine Plan |
V. |
|
Microbial Threats to Health and Global Collaboration Against
Infectious Diseases |
VI. |
|
The Status of Vaccine Development -- 1993 |
VII. |
|
The Status of Immunization - 1993 |
VIII. |
|
Development, Licensure, Recommendations for Use, and Postmarketing
Surveillance of Vaccines |
IX. |
|
Priorities for FY 1994 and FY 1995 |
X. |
|
Coordination |
XI. |
|
Overview of Investment and Resource Allocation |
XII. |
|
Predicted Outcomes of the National Vaccine Plan |
References |
|
Appendixes |
1. |
|
Statutory Basis for the National Vaccine Plan: Title XXI of the
Public Health Service Act (P.L. 99-660) |
2. |
|
Major Federal Organizations Responsible for Vaccine- and
lmmunization-Related Activities |
3. |
|
List of Participants in the Development of the National Vaccine
Plan |
4. |
|
Centers for Disease Control and Prevention, "Addressing Emerging
Infectious Disease Threats to Health: A Prevention Strategy for the United States"
(Excerpts) |
5. |
|
Licensed Vaccines Currently Distributed in the United States |
6. |
|
National Institute of Allergy and Infectious Diseases, "NIAID
Blue Ribbon Panel on Vaccine Research, March 26, 1993: Summary" |
7. |
|
Reported Cases of Vaccine-Preventable Diseases |
8. |
|
Measles Cases, 1989-1991 |
9. |
|
The Childhood Immunization Initiative: Purpose and Targets |
10. |
|
Centers for Disease Control and Prevention, "Childhood
Immunization Initiative Action Plan" |
11. |
|
Summary Excerpts from Benefit/Cost Studies of Immunization |
12. |
|
Acronyms and Abbreviations Used in the Plan |
|
Illustrations |
Table 1: |
Changes in the incidence of vaccine-preventable disease in the
United States |
Table 2: |
Estimates of current vaccine coverage or immunity among American
adults |
Table 3: |
Estimated effect of full use of vaccines currently recommended for
adults |
Table 4: |
Benefit/cost ratios of immunization for measles, mumps, and
rubella |
Table 5: |
Federal appropriations for vaccine development and immunization
programs, FY 1991 to FY 1994 |
Table 6: |
Number of cases reported in the United States in 1992-1993 for
diseases preventable by routine childhood vaccination, and CII targets for 1996 |
Table 7: |
Vaccination coverage targets of CII by vaccine and year |
Table 8: |
Coverage of the Childhood Immunization Initiative in the National
Vaccine Plan
|